Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer:
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?Prostate Cancer and Prostatic Diseases, 2001
- The bicalutamide Early Prostate Cancer Program: DemographyUrologic Oncology: Seminars and Original Investigations, 2001
- Gynecomastia in patients with prostate cancer: a review of treatment optionsUrology, 2000
- BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUPJournal of Urology, 2000
- IMMEDIATE OR DELAYED ENDOCRINE TREATMENT FOR LYMPH NODE METASTASIZED PROSTATE CANCER, IS THERE A BEST CHOICE?Journal of Urology, 1999
- The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U. S.Cancer, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trialBritish Journal of Urology, 1997
- Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancerCancer, 1994
- Deoxyribonucleic Acid Ploidy of Core Biopsies and Metastatic Lymph Nodes of Prostate Cancer Patients: Impact On Time to ProgressionJournal of Urology, 1993